文献速递心力衰竭与心肌病

AGO2通过激活线粒体基因翻译保护糖尿病心肌病

AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation.
PubMed 文献 · Circulation · 2023-12-21

该研究在小鼠糖尿病及糖尿病心肌病模型中阐明亚细胞定位AGO2的功能与机制。糖尿病心肌细胞线粒体中AGO2减少,过表达线粒体AGO2可减轻糖尿病诱导的心功能障碍。AGO2招募TUFM激活电子传递链亚基翻译并减少活性氧,而丙二酰化修饰减少AGO2进入线粒体,该修饰受胞质短亚型SIRT3的去丙二酰化功能调控。

要点

  • 糖尿病心肌细胞线粒体中AGO2减少,过表达线粒体AGO2可减轻心功能障碍。
  • AGO2招募TUFM激活电子传递链亚基翻译并减少活性氧。
  • AGO2丙二酰化减少其线粒体输入,受胞质短亚型SIRT3去丙二酰化调控。

核心结论

  • SIRT3-AGO2-CYTB轴将糖毒性偶联至心脏电子传递链失衡,为糖尿病心肌病提供线粒体靶向治疗依据。

研究设计与样本

  • 研究在小鼠糖尿病及糖尿病心肌病模型中阐明亚细胞定位AGO2的功能与机制。
  • 采用重组腺相关病毒9型经尾静脉递送AGO2至小鼠。
  • 通过超声心动图和导管测压系统评估心脏结构与功能。

主要发现

  • 糖尿病心肌细胞线粒体中AGO2减少。
  • 过表达线粒体AGO2减轻糖尿病诱导的心功能障碍。
  • AGO2招募线粒体翻译延伸因子TUFM激活电子传递链亚基翻译并减少活性氧。
  • AGO2的丙二酰化修饰在糖尿病心肌病中减少其进入线粒体。
  • AGO2丙二酰化受胞质定位的SIRT3短亚型通过先前未知的去丙二酰化功能调控。

临床怎么用

  • 本研究提示线粒体AGO2及SIRT3-AGO2-CYTB轴可能作为糖尿病心肌病的线粒体靶向干预方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetes is associated with cardiovascular complications. microRNAs translocate into subcellular organelles to modify genes involved in diabetic cardiomyopathy. However, functional properties of subcellular AGO2 (Argonaute2), a core member of miRNA machinery, remain elusive. METHODS: We elucidated the function and mechanism of subcellular localized AGO2 on mouse models for diabetes and diabetic cardiomyopathy. Recombinant adeno-associated virus type 9 was used to deliver AGO2 to mice through the tail vein. Cardiac structure and functions were assessed by echocardiography and catheter manometer system. RESULTS: AGO2 was decreased in mitochondria of diabetic cardiomyocytes. Overexpression of mitochondrial AGO2 attenuated diabetes-induced cardiac dysfunction. AGO2 recruited TUFM, a mitochondria translation elongation factor, to activate translation of electron transport chain subunits and decrease reactive oxygen species. Malonylation, a posttranslational modification of AGO2, reduced the importing of AGO2 into mitochondria in diabetic cardiomyopathy. AGO2 malonylation was regulated by a cytoplasmic-localized short isoform of SIRT3 through a previously unknown demalonylase function. CONCLUSIONS: Our findings reveal that the SIRT3-AGO2-CYTB axis links glucotoxicity to cardiac electron transport chain imbalance, providing new mechanistic insights and the basis to develop mitochondria targeting therapies for diabetic cardiomyopathy.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zhan J, Jin K, Xie R, et al. AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation. Circulation. 2023. PMID: 38126189. doi:10.1161/CIRCULATIONAHA.123.065546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。